Price T Rowe Associates Inc I Bio, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $4,676 - $9,353	-20,333 Reduced 5.93%	322,700 $85,000
Q1 2022 May 16, 2022	BUY	$0.3 - $0.61 $1,800 - $3,660	6,000 Added 1.78%	343,033 $147,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $101,420 - $191,776	184,400 Added 120.81%	337,033 $185,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $41,114 - $55,605	-33,700 Reduced 18.09%	152,633 $230,000
Q1 2021 May 17, 2021	SELL	$1.18 - $2.62 $43,095 - $95,687	-36,522 Reduced 16.39%	186,333 $287,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $233,997 - $499,195	222,855 New	222,855 $234,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.